Asset Details
Do you wish to reserve the book?
A Randomized Clinical Trial of Propranolol for the Prevention of Initial Bleeding in Cirrhosis with Portal Hypertension
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Randomized Clinical Trial of Propranolol for the Prevention of Initial Bleeding in Cirrhosis with Portal Hypertension
Do you wish to request the book?
A Randomized Clinical Trial of Propranolol for the Prevention of Initial Bleeding in Cirrhosis with Portal Hypertension
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Randomized Clinical Trial of Propranolol for the Prevention of Initial Bleeding in Cirrhosis with Portal Hypertension
1986
Overview
To the Editor:
Propranolol reduces portal hypertension in cirrhosis
1
and has been evaluated for the prevention of rebleeding.
2
,
3
We report here preliminary results of a multicenter randomized clinical trial in patients with cirrhosis who had never bled but were at high risk of bleeding (patients with large varices on endoscopy: \"F3,\" according to the criteria of the Japanese Research Society for Portal Hypertension
4
). Subjects with tense ascites, a bilirubin level over 3 mg per deciliter, heart failure, obstructive lung disease, or hepatocellular carcinoma were excluded. This allowed the admission of 174 patients of 220 consecutively observed at four centers . . .
Publisher
Massachusetts Medical Society
